Core Viewpoint - The announcement provides an overview of Nanjing Well Pharmaceutical Group Co., Ltd.'s 2025 semi-annual report, emphasizing the company's commitment to transparency and accuracy in its financial disclosures [4][6]. Company Overview - Nanjing Well Pharmaceutical Group Co., Ltd. specializes in the research, development, production, and sales of pharmaceutical excipients and synthetic lubricating base oil products [4]. Financial Data - The semi-annual report includes key operational data, although specific figures for production, sales, and revenue are not detailed in the provided text [4]. - The report indicates that there were no significant changes in the company's operational situation during the reporting period [4]. Important Events - The company will hold a semi-annual performance briefing on August 28, 2025, to discuss its financial results and operational performance with investors [8][10]. - Investors can submit questions for the briefing from August 21 to August 27, 2025, through the Shanghai Stock Exchange Roadshow Center [9][10].
南京威尔药业集团股份有限公司2025年半年度报告摘要